WDR5 and synovial sarcoma: Such SS-killing effects were not seen with the matched WDR5 protein-protein interaction (PPI) inhibitor or the designed PROTAC-inactive analog compounds, pointing to WDR5 degradation to be necessary for efficiently suppressing SS cell growth.